Aniline
| Aniline | |
|---|---|
| Salts [] | |
|---|---|
| Aniline hemisulfate | |
| Aniline hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 93.13 g/mol [1] |
| Appearance | Oily liquid; colorless when freshly distilled, darkens on exposure to air and light [1] |
| Odor | Hedonic tone; pungent [1] |
| Taste | Burning taste [1] |
| Density | 1.022 at 68 °F (EPA, 1998) - Denser than water; will sink [1] |
| Melting point | 21 °F (EPA, 1998) [1] |
| Boiling point | 363 to 367 °F at 760 mmHg (EPA, 1998) [1] |
| Decomposition | Hazardous decomposition products formed under fire conditions - Carbon oxides, nitrogen oxides (NOx). [1] |
| Solubility | 10 to 50 mg/mL at 73 °F (NTP, 1992) [1] |
| Predicted LogP | 0.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C6H7N |
| IUPAC name | aniline |
| SMILES | C1=CC=C(C=C1)N |
| InChI | InChI=1S/C6H7N/c7-6-4-2-1-3-5-6/h1-5H,7H2 |
| InChIKey | PAYRUJLWNCNPSJ-UHFFFAOYSA-N |
| CAS number | 62-53-3 |
| UNII | SIR7XX2F1K |
| PubChem CID | 6115 |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - oral: 250 mg/kg - dermal: 1400 mg/kg - ip: 420 mg/kg [1] |
| LC50 | Mouse: - inhalation: 175 ppm/7 [1] |
Aniline (also known as Benzenamine, Phenylamine, Aminobenzene, Aminophen, Arylamine, Kyanol, Anilin, Cyanol, Benzidam or Krystallin) is a substance of the aniline class.
Chemistry
Salts []
Stereochemistry []
Aniline is achiral.
Druglikeness
Lipinski's rule of five
Aniline matches Lipinski's rule of five.Pharmacology
MeSH Classification
- carcinogens (M0003416)
Mechanism of action []
Aniline exposure is associated with toxicity to the spleen leading to splenomegaly, hyperplasia, fibrosis and a variety of sarcomas of the spleen on chronic exposure. In earlier studies, we have shown that aniline exposure leads to iron overload, oxidative stress and activation of redox-sensitive transcription factors, which could regulate various genes leading to a tumorigenic response in the spleen. However, molecular mechanisms leading to aniline-induced cellular proliferation in the spleen remain largely unknown. This study was, therefore, undertaken on the regulation of G1 phase cell cycle proteins (cyclins), expression of cyclin-dependent kinases (CDKs), phosphorylation of retinoblastoma protein (pRB) and cell proliferation in the spleen, in an experimental condition preceding a tumorigenic response. Male SD rats were treated with aniline (0.5 mmol/kg/day via drinking water) for 30 days (controls received drinking water only), and splenocyte proliferation, protein expression of G1 phase cyclins, CDKs and pRB were measured. Aniline treatment resulted in significant increases in splenocyte proliferation, based on cell counts, cell proliferation markers including proliferating cell nuclear antigen (PCNA), nuclear Ki67 protein (Ki67) and minichromosome maintenance (MCM), MTT assay and flow cytometric analysis. Western blot analysis of splenocyte proteins from aniline-treated rats showed significantly increased expression of cyclins D1, D2, D3 and E, as compared to the controls. Similarly, real-time PCR analysis showed significantly increased mRNA expression for cyclins D1, D2, D3 and E in the spleens of aniline-treated rats. The overexpression of these cyclins was associated with increases in the expression of CDK4, CDK6, CDK2 as well as phosphorylation of pRB protein. Our data suggest that increased expression of cyclins, CDKs and phosphorylation of pRB protein could be critical in cell proliferation, and may contribute to aniline-induced tumorigenic response in the spleen. [1]
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 6115, Aniline. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/6115
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Aniline. UNII: SIR7XX2F1K. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/SIR7XX2F1K
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 08:59:19 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 08:59:15 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 08:59:15 |
| gsrs | ok | 2026-11-20 08:59:16 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0003012) | 2026-11-20 08:59:15 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 08:59:18 |
| pubchem | ok | 2026-11-20 08:59:14 |
| missing (no r/tripreports posts mention it) | 2026-11-20 08:59:15 | |
| sider | missing (not in SIDER) | 2026-11-20 08:59:15 |
| structure | ok | 2026-11-20 08:59:15 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 08:59:15 |